A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer

European Journal of Cancer

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2gafCTa
via IFTTT